The global renal insufficiency treatment market has demonstrated significant growth, achieving a market value of USD 13.24 Billion in 2023, and is projected to reach an impressive USD 35.28 Billion by 2033. This surge represents a robust compound annual growth rate (CAGR) of 10.3% during the forecast period from 2023 to 2033, a substantial improvement …